| Dr Thomas Christopher Portman, PHD | |
|
1118 Finnegan Way, Suite 104, Bellingham, WA 98225-6622 | |
| (360) 733-4502 | |
| (360) 733-7594 |
| Full Name | Dr Thomas Christopher Portman |
|---|---|
| Gender | Male |
| Speciality | Clinical Psychologist |
| Experience | 37 Years |
| Location | 1118 Finnegan Way, Bellingham, Washington |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063473353 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 103T00000X | Psychologist | 1615 (Washington) | Primary |
| Entity Name | T Christopher Portman Phd Ps |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1982833448 PECOS PAC ID: 7315099215 Enrollment ID: O20090812000327 |
News Archive
Under the plan, insurance companies would pick up the cost for providing contraceptives to women employed by religious affiliated employers, but the administration offered ways to help cover those expenses.
Patients suffering from a stroke are more likely to have improved outcomes and fewer complications when hospitals use standardized guidelines for stroke care during a patient's admission and discharge from the hospital, according to a study led by researchers at UCSF Medical Center.
Researchers from Boston University School of Medicine have found that the diabetic drug, pramlintide, reduces amyloid-beta peptides, a major component of Alzheimer's disease (AD) in the brain and improves learning and memory in two experimental AD models.
The Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) is to establish 20 Collaborative Research Centres (CRCs) by 1 July 2012. This decision was taken by the Grants Committee at its spring session in Bonn. The new CRCs will receive funding totalling 176 million euros (including a 20 percent programme allowance for indirect project costs) for the initial 4-year funding period.
Entest BioMedical Inc. (OTC Bulletin Board: ENTB) announced today the filing of a third patent application relating to the area of chronic obstructive pulmonary disease (COPD), a condition that affects more than 5 million patients in the United States, resulting in more than 120,000 deaths per year. The application covers an implantable medical device useful in re-directing the immune system to stop tissue inflammation.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Thomas Christopher Portman, PHD 1201 13th St, Ste 102, Bellingham, WA 98225-7154 Ph: (360) 733-4502 | Dr Thomas Christopher Portman, PHD 1118 Finnegan Way, Suite 104, Bellingham, WA 98225-6622 Ph: (360) 733-4502 |
News Archive
Under the plan, insurance companies would pick up the cost for providing contraceptives to women employed by religious affiliated employers, but the administration offered ways to help cover those expenses.
Patients suffering from a stroke are more likely to have improved outcomes and fewer complications when hospitals use standardized guidelines for stroke care during a patient's admission and discharge from the hospital, according to a study led by researchers at UCSF Medical Center.
Researchers from Boston University School of Medicine have found that the diabetic drug, pramlintide, reduces amyloid-beta peptides, a major component of Alzheimer's disease (AD) in the brain and improves learning and memory in two experimental AD models.
The Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) is to establish 20 Collaborative Research Centres (CRCs) by 1 July 2012. This decision was taken by the Grants Committee at its spring session in Bonn. The new CRCs will receive funding totalling 176 million euros (including a 20 percent programme allowance for indirect project costs) for the initial 4-year funding period.
Entest BioMedical Inc. (OTC Bulletin Board: ENTB) announced today the filing of a third patent application relating to the area of chronic obstructive pulmonary disease (COPD), a condition that affects more than 5 million patients in the United States, resulting in more than 120,000 deaths per year. The application covers an implantable medical device useful in re-directing the immune system to stop tissue inflammation.
› Verified 8 days ago
Patricia A Marek, PHD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 1201 11th Street Suite 201, Bellingham, WA 98225 Phone: 360-647-2808 Fax: 360-752-0037 | |
Dr. Steve Call, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 801 Samish Way, Bellingham, WA 98229 Phone: 425-753-3547 | |
Kathryn Oost, PHD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 1140 10th St Ste 203, Bellingham, WA 98225 Phone: 360-603-0518 | |
Nahid Markosian, PH.D. Psychologist Medicare: Accepting Medicare Assignments Practice Location: 12 Bellwether Way, Suite 223, Bellingham, WA 98225 Phone: 360-255-2505 Fax: 360-255-2504 | |
Dr. Cara Joann Anderson, PSY.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 1155 N State St, Bellingham, WA 98225 Phone: 360-255-2505 Fax: 360-255-2504 | |
Dr. Susan D. Kane-ronning, PH.D. Psychologist Medicare: Medicare Enrolled Practice Location: 1117 Ellis St, Bellingham, WA 98225 Phone: 360-714-8109 Fax: 360-756-8936 |